Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000023

President and CEO sold 5,461 shares at $4.26 ($23,257)

  • President and CEO acquired 10,937 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Brunn Carsten · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-01 Exercise or conversion : show line 1 in the form +10,937 222,287 D
2021-03-02 Sale : show line 2 in the form −5,461 $4.26 $23,257 216,826 D
Open-market sales · 5,461 sh · avg $4.26 · $23,257

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −10,937 76,563 D
Loading xslF345X03/wf-form4_161481004616254.xml…